Developing advanced tools for analyzing genetic data in cancer research
Official title: Core 2: Bioinformatics/Biostatistics/Genomics
Funded at Sanford Burnham Prebys Medical Discovery Institute · NIH-10935869 · Data updated 2026-11-12
This study is working on a new platform that combines different scientific tools to help understand cancer better by looking at genetic data, which could lead to new insights that might improve treatment options for patients like you.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sanford Burnham Prebys Medical Discovery Institute NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project start | September 9, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $312,345 |
| NIH project number | 1P01CA281819-01A1 |
| Project ID | NIH-10935869 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are cancer patients who may have specific genetic alterations or mutations being studied.
✕Less likely to help
Patients with non-cancerous conditions or those not exhibiting relevant genetic markers may not benefit from this research.
What this research studies
This research focuses on creating a comprehensive platform that integrates bioinformatics, biostatistics, and genomics to analyze genetic data related to cancer. It aims to support various projects by providing tools for both exploratory and hypothesis-driven analyses, helping to identify key molecules and pathways involved in cancer progression. By examining sequencing data, the research will explore changes in mutations and their implications for cancer treatment. Patients may benefit from the insights gained through this integrated approach to understanding cancer biology.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding of cancer mechanisms and more targeted therapies for patients.
How similar studies have gone: Previous research in bioinformatics and genomics has shown success in identifying critical pathways in cancer, suggesting that this approach is promising.
Where this research is happening
-
Sanford Burnham Prebys Medical Discovery Institute
La Jolla, United States Active
Researchers
- Principal investigator: Tamayo, Pablo — Sanford Burnham Prebys Medical Discovery Institute
- Study coordinator: Tamayo, Pablo
Related research
Other NIH-funded projects on the same topics.
-
Aging and liver cancer: new ways to prevent and fight hepatocellular carcinoma
This research explores how aging promotes liver cancer and tests new preventive approaches that could help people at higher risk due to age.
-
EPHA2 signaling and breast cancer spread tied to the body’s stiffness
This grant explores how the EPHA2 receptor helps breast cancer cells respond to the stiffness of their surroundings and whether activating EPHA2’s normal signaling can block cancer invasion.
-
Molecule-focused study on soluble TREM2 in Alzheimer's disease
A study to understand how soluble TREM2 in the brain and spinal fluid may influence Alzheimer's disease in people with the condition or at risk for it.
-
How NRF2 and FBP1 control liver metabolism
This work looks at whether changes in two liver proteins, NRF2 and FBP1, help explain low blood sugar and fat buildup in the liver for people with metabolic liver problems or rare FBP1 deficiency.
-
How mitochondrial and immune signals drive inflammation linked to Alzheimer's
This project looks at how damaged mitochondria and immune signaling cause inflammation that may contribute to Alzheimer's disease.
-
Nup210’s role in leukemia and its potential as a target
A doctor-scientist team is studying how a protein called Nup210 helps a type of blood cancer (AML) grow, with the goal of finding new ways to predict outcomes and treat the disease.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.